835 studies found for:    Open Studies | "Blood Coagulation Disorders"
Show Display Options
Rank Status Study
21 Unknown  The Effect of a Levonorgestrel-releasing Intrauterine Device (IUD) Versus a Copper Containing IUD on Risk of Blood Clots
Condition: Blood Coagulation Disorders
Interventions: Device: Levonorgestrel-containing IUD (Mirena®);   Device: Copper-containing IUD (Paraguard®)
22 Unknown  "Salvage Use" of Recombinant Factor VIIa After Inadequate Haemostasis in Complex Cardiac Surgery
Conditions: Myocardial Ischemia;   Blood Coagulation Disorders;   Coronary Artery Disease;   Heart Valve Diseases
Intervention: Drug: Recombinant Activated Factor VII
23 Recruiting Study of a Prothrombin Complex Concentrate for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Japanese Subjects
Conditions: Acute Major Bleeding;   Reversal of Coagulopathy
Intervention: Biological: BE1116 (Prothrombin Complex Concentrate)
24 Recruiting Ex Vivo Laboratory Assays Application for Therapy Tailoring in Patients With Severe Bleeding Disorders
Condition: Severe Hemophilia
Intervention:
25 Recruiting To Investigate Safety and Efficacy of NovoEight® (rFVIII) During Long-term Treatment of Haemophilia A in Japan
Conditions: Congenital Bleeding Disorder;   Haemophilia A
Intervention: Drug: turoctocog alfa
26 Recruiting Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B
Conditions: Congenital Bleeding Disorder;   Haemophilia B
Intervention: Drug: nonacog beta pegol
27 Recruiting Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Conditions: Congenital Bleeding Disorder;   Haemophilia A
Intervention: Drug: turoctocog alfa
28 Recruiting Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Conditions: Congenital Bleeding Disorder;   Haemophilia A
Intervention: Drug: turoctocog alfa pegol
29 Recruiting Fibrinogen in the Initial Resuscitation of Severe Trauma (FiiRST)
Conditions: Trauma;   Injury;   Bleeding;   Haemorrhage;   Coagulopathy
Interventions: Drug: Fibrinogen concentrate;   Drug: Placebo Comparator
30 Recruiting Safety Study of Spray-Dried Solvent/Detergent-Treated Plasma for Infusion in Healthy Volunteers
Condition: Coagulation Defects
Interventions: Biological: Spray-dried S/D-treated Plasma;   Drug: Spray-dried S/D-treated plasma
31 Not yet recruiting Post-Marketing Requirement to Evaluate the Safety of Octaplas™ Versus Plasma in Patients Undergoing Orthotopic Liver Transplantation With Special Emphasis on Hyperfibrinolysis.
Conditions: Coagulopathy;   Endstage Liver Disease
Interventions: Biological: Octaplas™;   Biological: Plasma
32 Recruiting RETIC Trial: Reversal of Trauma Induced Coagulopathy Using Coagulation Factor Concentrates or Fresh Frozen Plasma
Condition: Major Trauma
Interventions: Drug: Fibrinogen concentrate, Prothrombin complex concentrate and FXIII concentrate;   Drug: Fresh Frozen Plasma blood type 0, A, B and AB
33 Recruiting Point-of-Care Testing in Coagulopathic Patients Undergoing Cardiac Surgery - a Multicenter Study
Condition: Coagulopathy During Cardiac Surgery
Interventions: Device: Conventional laboratory testing (Central laboratory);   Device: POC testing
34 Recruiting Trial of HoLEP vs. PVP in Treating BPH in Patients With Bleeding Tendency
Condition: Benign Prostatic Hyperplasia
Interventions: Procedure: HoLEP;   Procedure: Greenlight laser PVP
35 Recruiting Coagulopathy and SIRS During ECC in Intensive Care
Condition: Disorder of Circulatory System
Intervention: Device: ECLS
36 Recruiting Standardisation of Investigations of Mild Bleeding Disorders
Condition: Hemorrhagic Disorders
Intervention: Other: Second step of investigations
37 Recruiting Octaplas Pediatric Plasma Replacement Trial
Conditions: Liver Surgery;   Liver Dysfunction;   Coagulopathy;   Cardiac Surgery
Intervention: Biological: octaplas
38 Recruiting Thromboelastography During Surgery for Malignant Pleural Mesothelioma
Conditions: Coagulopathy;   Mesothelioma
Intervention: Procedure: Blood draw for TEG analysis
39 Recruiting Safety and Efficacy Study Comparing Pad-gauze With Anti-fibrinolytic Agent Hemostopan™) to a Regular Pad-gauze
Conditions: Bleeding;   Coagulopathy
Intervention: Device: pad-gauze with tranexamic acid (Hemostopan™)
40 Unknown  Efficacy and Safety of Heparin-grafted Membrane for CRRT
Conditions: Acute Kidney Injury;   Hemorrhage;   Coagulopathy
Interventions: Device: oXiris as first filter;   Device: M150 as first filter

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years